| Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients. | Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients.
Pàmies A, Llop D, Ibarretxe D, Rosales R, Girona J, Masana L, Vallvé JC, Paredes S., Free PMC Article | 10/7/2024 |
| The Role of Catestatin in Preeclampsia. | The Role of Catestatin in Preeclampsia.
Bralewska M, Pietrucha T, Sakowicz A., Free PMC Article | 03/14/2024 |
| Low catestatin as a risk factor for cardiovascular disease - assessment in patients with adrenal incidentalomas. | Low catestatin as a risk factor for cardiovascular disease - assessment in patients with adrenal incidentalomas.
Zalewska E, Kmieć P, Sobolewski J, Koprowski A, Sworczak K., Free PMC Article | 08/3/2023 |
| Salivary cortisol, dehydroepiandrosterone, and chromogranin A levels in patients with gingivitis and periodontitis and a novel biomarker for psychological stress. | Salivary cortisol, dehydroepiandrosterone, and chromogranin A levels in patients with gingivitis and periodontitis and a novel biomarker for psychological stress.
Lee YH, Suk C, Shin SI, Hong JY., Free PMC Article | 05/3/2023 |
| Effects of the SPI/lncRNA NEAT1 Axis on Functions of Trophoblast and Decidual Cells in Patients with Recurrent Miscarriage. | Effects of the SPI/lncRNA NEAT1 Axis on Functions of Trophoblast and Decidual Cells in Patients with Recurrent Miscarriage.
Tian F, Zhang Y, Li J, Chu Z, Zhang J, Han H, Jia L. | 04/7/2023 |
| Role of Chromogranin A in the Diagnosis and Follow-up of Neuroendocrine Tumors: Real-World Experience. | Role of Chromogranin A in the Diagnosis and Follow-up of Neuroendocrine Tumors: Real-World Experience.
Nguyen M, Li M, Travers A, Segelov E. | 01/28/2023 |
| Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma. | Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
Baykara Y, Xiao Y, Yang D, Yakirevich E, Maleki S, Garcia-Moliner M, Wang LJ, Huang CK, Lu S. | 07/2/2022 |
| Serum Vasostatin-1 Level is Increased in Women with Preeclampsia. | Serum Vasostatin-1 Level is Increased in Women with Preeclampsia.
Tüten A, Tüten N, Gök K, Hamzaoglu K, Bulut H, Malik E, Guralp O. | 06/18/2022 |
| Chromogranin A plasma levels predict mortality in COVID-19. | Chromogranin A plasma levels predict mortality in COVID-19.
De Lorenzo R, Sciorati C, Ramirez GA, Colombo B, Lorè NI, Capobianco A, Tresoldi C, Bio Angels for COVID-BioB Study Group, Cirillo DM, Ciceri F, Corti A, Rovere-Querini P, Manfredi AA., Free PMC Article | 04/30/2022 |
| Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders. | Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
Allu PKR, Kiranmayi M, Mukherjee SD, Chirasani VR, Garg R, Vishnuprabu D, Ravi S, Subramanian L, Sahu BS, Iyer DR, Maghajothi S, Sharma S, Ravi MS, Khullar M, Munirajan AK, Gayen JR, Senapati S, Mullasari AS, Mohan V, Radha V, Naga Prasad SV, Mahapatra NR. | 03/5/2022 |
| Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms. | Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms.
Yu F, Fu J, Zhang C, Wu W, Ai S, Yao X, Meng Q, Huang Y, Lu G, Wang F, Qu W. | 02/12/2022 |
| The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma. | The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
Murakami K, Kumata H, Miyagi S, Kamei T, Sasano H. | 02/12/2022 |
| Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation. | Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation.
Orth-Alampour S, Gayrard N, Salem S, Bhargava S, Jankowski V, Jover B, Notarnicola C, Noels H, van der Vorst EPC, Kuppe C, Wolf M, Goettsch C, Theelen W, Bruck H, Fliser D, Loscalzo J, Wu Z, Marx N, Zidek W, Argilés À, Jankowski J., Free PMC Article | 01/22/2022 |
| Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma. | Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.
Tomita T., Free PMC Article | 01/22/2022 |
| Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy. | Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy.
Bralewska M, Biesiada L, Grzesiak M, Rybak-Krzyszkowska M, Huras H, Gach A, Pietrucha T, Sakowicz A., Free PMC Article | 01/15/2022 |
| False-Positive Pancreastatin Results From a Commercial Laboratory: A Report of 2 Cases. | False-Positive Pancreastatin Results From a Commercial Laboratory: A Report of 2 Cases.
Sagum J, Yu R. | 01/1/2022 |
| Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning. | Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning.
Reza MI, Syed AA, Singh P, Husain A, Gayen JR. | 10/9/2021 |
| Chromogranin-A serum levels in patients with takotsubo syndrome and ST elevation acute myocardial infarction. | Chromogranin-A serum levels in patients with takotsubo syndrome and ST elevation acute myocardial infarction.
Tarantino N, Santoro F, Di Biase L, Di Terlizzi V, Vitale E, Barone R, Della Rocca DG, De Leon De La Cruz NS, Di Biase M, Brunetti ND. | 07/10/2021 |
| Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population. | Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population.
Hong L, Wang Y, Zhang T, Zhang C, Wang L, Wang L, Wang Z, Zhong J., Free PMC Article | 05/22/2021 |
| Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive Study. | Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive Study.
Eissa N, Hussein H, Tshikudi DM, Hendy GN, Bernstein CN, Ghia JE., Free PMC Article | 03/13/2021 |
| Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity. | Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.
Ebert A, König J, Frommer L, Schuppan D, Kahaly GJ. | 02/13/2021 |
| Serum CST concentration is lower in coronary artery disease patients and is inversely associated with the severity of atherosclerosis. | Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.
Chen Y, Wang X, Yang C, Su X, Yang W, Dai Y, Han H, Jiang J, Lu L, Wang H, Chen Q, Jin W. | 04/18/2020 |
| Obese subjects with metabolic syndrome have lower serum catestatin concentrations than obese subjects without metabolic syndrome and controls. | Serum catestatin concentrations are decreased in obese children and adolescents.
Simunovic M, Supe-Domic D, Karin Z, Degoricija M, Paradzik M, Bozic J, Unic I, Skrabic V. | 03/14/2020 |
| Studied association of progastrin-releasing peptide (proGRP), neuron specific enolase (NSE), chromogranin a (CgA), and squamous cell cancer antigen (SCCA1) in pulmonary neuroendocrine tumor (PNET) and non-small-cell lung carcinoma (NSCLC). Results showed ProGRP can distinguish PNET patients from NSCLC patients, and with adjusted NSE values, it can differentiate the PNET group from the benign disease group. | Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors.
Tutar N, Yetkin NA, Yazıcı C, Önal Ö, Kontaş O, Keleştemur F., Free PMC Article | 02/22/2020 |
| High chromogranin A (CgA) levels may predict poor prognosis in patients with pancreatic cancer, especially during metastatic stages. | Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma.
Lee SH, Jo JH, Kim YJ, Lee HS, Chung MJ, Park JY, Bang S, Park SW, Song SY. | 02/22/2020 |